Teva 2Q profit slips on Barr costs

NEW YORK - Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker by revenue, said its profit slipped 2 percent in the second quarter due to expenses related to its purchase of Barr Pharmaceuticals.

Copyright PHILY - Philly.com
Contact Us